NCT05594017View on ClinicalTrials.gov

Pharmacological Modulation of Brain Oscillations in Memory Processing

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions
EpilepsySeizuresCognitive Impairment, MildMemory DisordersMemory Loss
Interventions
DRUG

Scopolamine (0.4mg)

Patient receives a dose of scopolamine (0.4mg) via IV fifteen minutes prior to spatial or episodic memory task/completion.

DRUG

Placebo

Patient receives a dose of saline via IV fifteen minutes prior to spatial or episodic memory task/completion.

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Texas Southwestern Medical Center

OTHER